Cancer treatment and survivorship statistics, 2022

Author:

Miller Kimberly D.1ORCID,Nogueira Leticia2ORCID,Devasia Theresa3,Mariotto Angela B.4,Yabroff K. Robin2,Jemal Ahmedin5,Kramer Joan6,Siegel Rebecca L.1ORCID

Affiliation:

1. Surveillance Research, American Cancer Society Atlanta Georgia

2. Health Services Research, American Cancer Society Atlanta Georgia

3. Data Analytics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland

4. Surveillance Research Program, Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland

5. Surveillance and Health Equity Science, American Cancer Society Atlanta Georgia

6. Department of Hematology and Medical Oncology Emory University Atlanta Georgia

Publisher

Wiley

Subject

Oncology,Hematology

Reference255 articles.

1. Is it time to reconsider the term “cancer survivor”?

2. Estimation and projections of cancer prevalence from cancer registry data

3. Surveillance Research Program National Cancer Institute. SEER*Stat software version 8.3.9. National Cancer Institute;2021.

4. Surveillance Research Program National Cancer Institute. SEER*Stat software version 8.3.5. National Cancer Institute;2018.

Cited by 1391 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3